BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

561 related articles for article (PubMed ID: 34344321)

  • 1. Prolonged viral shedding of SARS-CoV-2 in two immunocompromised patients, a case report.
    Niyonkuru M; Pedersen RM; Assing K; Andersen TE; Skov MN; Johansen IS; Madsen LW
    BMC Infect Dis; 2021 Aug; 21(1):743. PubMed ID: 34344321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged SARS-Cov-2 shedding with rapid IgG antibody decay in a COVID-19 patient: A case report.
    Huang J; Lan C; Wang X; Huang M
    J Clin Lab Anal; 2021 Nov; 35(11):e24002. PubMed ID: 34528306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged viral shedding of SARS-CoV-2 in an immunocompromised patient.
    Nakajima Y; Ogai A; Furukawa K; Arai R; Anan R; Nakano Y; Kurihara Y; Shimizu H; Misaki T; Okabe N
    J Infect Chemother; 2021 Feb; 27(2):387-389. PubMed ID: 33328135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes mellitus is a risk factor for prolonged SARS-CoV-2 viral shedding in lower respiratory tract samples of critically ill patients.
    Buetti N; Trimboli P; Mazzuchelli T; Lo Priore E; Balmelli C; Trkola A; Conti M; Martinetti G; Elzi L; Ceschi A; Consonni V; Ogna A; Forni-Ogna V; Bernasconi E
    Endocrine; 2020 Dec; 70(3):454-460. PubMed ID: 32870469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged Shedding of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at High Viral Loads Among Hospitalized Immunocompromised Persons Living With Human Immunodeficiency Virus (HIV), South Africa.
    Meiring S; Tempia S; Bhiman JN; Buys A; Kleynhans J; Makhasi M; McMorrow M; Moyes J; Quan V; Walaza S; du Plessis M; Wolter N; von Gottberg A; Cohen C;
    Clin Infect Dis; 2022 Aug; 75(1):e144-e156. PubMed ID: 35134129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shedding of infectious SARS-CoV-2 by hospitalized COVID-19 patients in relation to serum antibody responses.
    Glans H; Gredmark-Russ S; Olausson M; Falck-Jones S; Varnaite R; Christ W; Maleki KT; Karlberg ML; Broddesson S; Falck-Jones R; Bell M; Johansson N; Färnert A; Smed-Sörensen A; Klingström J; Bråve A
    BMC Infect Dis; 2021 May; 21(1):494. PubMed ID: 34044758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of SARS-CoV-2 in Viral Cell Culture in Immunocompromised Patients With Persistently Positive RT-PCR Results.
    Sung A; Bailey AL; Stewart HB; McDonald D; Wallace MA; Peacock K; Miller C; Reske KA; O'Neil CA; Fraser VJ; Diamond MS; Burnham CD; Babcock HM; Kwon JH
    Front Cell Infect Microbiol; 2022; 12():804175. PubMed ID: 35186791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duration of Replication-Competent Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Shedding Among Patients With Severe or Critical Coronavirus Disease 2019 (COVID-19).
    Kim DY; Lin MY; Jennings C; Li H; Jung JH; Moore NM; Ghinai I; Black SR; Zaccaro DJ; Brofman J; Hayden MK;
    Clin Infect Dis; 2023 Feb; 76(3):e416-e425. PubMed ID: 35607802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral Haplotypes in COVID-19 Patients Associated With Prolonged Viral Shedding.
    Wu Y; Zheng S; Liu T; Liu X; Tang H; He Y; Xu W; Li L; Yu W; Xing K; Xia X
    Front Cell Infect Microbiol; 2021; 11():715143. PubMed ID: 34858866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 in an immunocompromised host: persistent shedding of viable SARS-CoV-2 and emergence of multiple mutations: a case report.
    Leung WF; Chorlton S; Tyson J; Al-Rawahi GN; Jassem AN; Prystajecky N; Masud S; Deans GD; Chapman MG; Mirzanejad Y; Murray MCM; Wong PHP
    Int J Infect Dis; 2022 Jan; 114():178-182. PubMed ID: 34757008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectiousness Among Three Immunocompromised Patients: From Prolonged Viral Shedding to SARS-CoV-2 Superinfection.
    Tarhini H; Recoing A; Bridier-Nahmias A; Rahi M; Lambert C; Martres P; Lucet JC; Rioux C; Bouzid D; Lebourgeois S; Descamps D; Yazdanpanah Y; Le Hingrat Q; Lescure FX; Visseaux B
    J Infect Dis; 2021 May; 223(9):1522-1527. PubMed ID: 33556961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Test-based de-isolation in COVID-19 immunocompromised patients: Cycle threshold value versus SARS-CoV-2 viral culture.
    Alshukairi AN; Tolah AM; Dada A; Al-Tawfiq JA; Almagharbi RS; Saeedi MF; Al-Hamzi MA; El-Kafrawy SA; Bahaudden HA; El-Saed A; Al-Mozaini MA; Khalid I; Hefni LK; Hassan AM; Alandijany TA; Bajrai LH; Bayumi DT; Albishi GE; Althawadi SI; Zabani NA; Perlman S; Azhar EI
    Int J Infect Dis; 2021 Jul; 108():112-115. PubMed ID: 34004329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics and potential factors for recurrence of positive SARS-CoV-2 RNA in convalescent patients: a retrospective cohort study.
    Ao Z; Li Y; Wei J; Jiang J; Wang X; Zhang P; Liu Y; Yu H; Zhu L; Wang X; Hu Q; Duan J; Hu W; Zhang X; Wu G; Guo S
    Clin Exp Med; 2021 Aug; 21(3):361-367. PubMed ID: 33543353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 late shedding may be infectious between immunocompromised hosts.
    Kaila V; Sirkeoja S; Blomqvist S; Rannikko J; Viskari H; Lyly-Yrjänäinen T; Syrjänen J
    Infect Dis (Lond); 2021 Nov; 53(11):880-882. PubMed ID: 34137349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamics of SARS-CoV-2 shedding in the respiratory tract depends on the severity of disease in COVID-19 patients.
    Munker D; Osterman A; Stubbe H; Muenchhoff M; Veit T; Weinberger T; Barnikel M; Mumm JN; Milger K; Khatamzas E; Klauss S; Scherer C; Hellmuth JC; Giessen-Jung C; Zoller M; Herold T; Stecher S; de Toni EN; Schulz C; Kneidinger N; Keppler OT; Behr J; Mayerle J; Munker S
    Eur Respir J; 2021 Jul; 58(1):. PubMed ID: 33602859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
    Wei J; Zhao J; Han M; Meng F; Zhou J
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged SARS-CoV-2 infection following rituximab treatment: clinical course and response to therapeutic interventions correlated with quantitative viral cultures and cycle threshold values.
    Thornton CS; Huntley K; Berenger BM; Bristow M; Evans DH; Fonseca K; Franko A; Gillrie MR; Lin YC; Povitz M; Shafey M; Conly JM; Tremblay A
    Antimicrob Resist Infect Control; 2022 Feb; 11(1):28. PubMed ID: 35123573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged shedding of severe acute respiratory syndrome coronavirus 2 in patients with COVID-19.
    Li Q; Zheng XS; Shen XR; Si HR; Wang X; Wang Q; Li B; Zhang W; Zhu Y; Jiang RD; Zhao K; Wang H; Shi ZL; Zhang HL; Du RH; Zhou P
    Emerg Microbes Infect; 2020 Dec; 9(1):2571-2577. PubMed ID: 33196399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of viral load and antibody response in relation to COVID-19 severity.
    Wang Y; Zhang L; Sang L; Ye F; Ruan S; Zhong B; Song T; Alshukairi AN; Chen R; Zhang Z; Gan M; Zhu A; Huang Y; Luo L; Mok CKP; Al Gethamy MM; Tan H; Li Z; Huang X; Li F; Sun J; Zhang Y; Wen L; Li Y; Chen Z; Zhuang Z; Zhuo J; Chen C; Kuang L; Wang J; Lv H; Jiang Y; Li M; Lin Y; Deng Y; Tang L; Liang J; Huang J; Perlman S; Zhong N; Zhao J; Malik Peiris JS; Li Y; Zhao J
    J Clin Invest; 2020 Oct; 130(10):5235-5244. PubMed ID: 32634129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors Associated With Prolonged Viral RNA Shedding in Patients with Coronavirus Disease 2019 (COVID-19).
    Xu K; Chen Y; Yuan J; Yi P; Ding C; Wu W; Li Y; Ni Q; Zou R; Li X; Xu M; Zhang Y; Zhao H; Zhang X; Yu L; Su J; Lang G; Liu J; Wu X; Guo Y; Tao J; Shi D; Yu L; Cao Q; Ruan B; Liu L; Wang Z; Xu Y; Liu Y; Sheng J; Li L
    Clin Infect Dis; 2020 Jul; 71(15):799-806. PubMed ID: 32271376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.